Householder Group Estate & Retirement Specialist LLC Has $43,000 Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Householder Group Estate & Retirement Specialist LLC lessened its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 18.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 84 shares of the medical equipment provider’s stock after selling 19 shares during the period. Householder Group Estate & Retirement Specialist LLC’s holdings in Intuitive Surgical were worth $43,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the company. Intech Investment Management LLC increased its holdings in shares of Intuitive Surgical by 6.2% during the second quarter. Intech Investment Management LLC now owns 21,279 shares of the medical equipment provider’s stock worth $9,466,000 after buying an additional 1,244 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its position in Intuitive Surgical by 5.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 6,450 shares of the medical equipment provider’s stock valued at $2,870,000 after acquiring an additional 338 shares during the last quarter. King Luther Capital Management Corp boosted its position in Intuitive Surgical by 2.1% during the second quarter. King Luther Capital Management Corp now owns 5,670 shares of the medical equipment provider’s stock valued at $2,522,000 after acquiring an additional 114 shares during the last quarter. AE Wealth Management LLC boosted its position in Intuitive Surgical by 24.5% during the second quarter. AE Wealth Management LLC now owns 3,822 shares of the medical equipment provider’s stock valued at $1,700,000 after acquiring an additional 752 shares during the last quarter. Finally, Sei Investments Co. boosted its position in Intuitive Surgical by 1.4% during the second quarter. Sei Investments Co. now owns 527,686 shares of the medical equipment provider’s stock valued at $234,734,000 after acquiring an additional 7,080 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 1.5 %

ISRG opened at $592.64 on Friday. The company has a 50 day moving average of $540.66 and a 200 day moving average of $498.77. The company has a market cap of $211.09 billion, a PE ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $362.14 and a 12 month high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Research analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares of the company’s stock, valued at $3,638,990. This trade represents a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 in the last three months. Company insiders own 0.80% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of a number of research analyst reports. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Raymond James increased their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Monday, October 14th. Stifel Nicolaus increased their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Robert W. Baird increased their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Finally, Citigroup increased their price objective on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.